Adrenaline autoinjectors for Australian out-of-hospital anaphylaxis: where to from here?
Intern Med J
; 54(1): 187-189, 2024 Jan.
Article
in En
| MEDLINE
| ID: mdl-37926733
ABSTRACT
Intramuscular adrenaline autoinjectors are accepted as first-line treatment for out-of-hospital anaphylaxis but face ongoing issues of patient nonadherence related to drug expiry, availability, correct administration, and public recognition of the disease. Adrenaline is associated with possible harms in patients with defined comorbidities but is still considered preferable. Further research and policy is required to facilitate the effective treatment of anaphylaxis.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Epinephrine
/
Anaphylaxis
Limits:
Humans
Country/Region as subject:
Oceania
Language:
En
Journal:
Intern Med J
Journal subject:
MEDICINA INTERNA
Year:
2024
Type:
Article
Affiliation country:
Australia